Constrictive pericarditis after high-dose chemotherapy [1]

Lancet

Volumn 350, Issue 9091, 1997, Pages 1601-

  Tulleken, J E ^a   Kooiman, C G H M ^a   Van der Werf, T S ^a   Zijlstra, J G ^a   De Vries, E G E ^a  

^a Division Intensive Respiratory Care   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; THIOTEPA;

BREAST CANCER; CHEMOTHERAPY; CONSTRICTIVE PERICARDITIS; DRUG MEGADOSE; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 0031556849     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64017-2     Document Type: Article

References (4)

1. Gradishar WJ, Tallman MS, Abrams JS. High-dose chemotherapy for breast cancer. Ann Intern Med 1996; 125: 599-604.
2. Antman KH, Rowlings PA, Vaughan WP, et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 1997; 15: 1870-79.
3. de Vries EGE, ten Vergert EM, Mastenbroek CG, Dalieso O, Rodenhuis S. Breast cancer studies in the Netherlands. Lancet 1996; 348: 407-08.
4. Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 1991; 9: 1215-23.